Skip to main content
55th ASAM Annual Conference Main banner
Final Program


Conference Program
Back

Elizabeth M. Salisbury-Afshar, MD, MPH, FAAFP, FACPM, DFASAM

Associate Professor
University of Wisconsin, Madison School of Medicine and Public Health, Wisconsin

Elizabeth Salisbury-Afshar, MD, MPH is a family medicine, preventive medicine/public health, and addiction medicine physician and is an Associate Professor at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin. She is core faculty for the Addiction Medicine Fellowship at the University of Wisconsin and her clinical roles include addiction medicine consult service and serving as Medical Director of a low barrier clinic serving people who use substances. She is also the Program Director of the Preventive Medicine Residency at UW-Madison and Medical Director of Harm Reduction Services at the Wisconsin Division of Public Health.
Most of Dr. Salisbury-Afshar's work has focused on expanding access to evidence based addiction treatment and harm reduction services. Past roles include serving as the Medical Director of Behavioral Health Systems Baltimore, as the Medical Director of Behavioral Health at the Chicago Department of Public Health, and as the Director of the Center for Addiction Research and Effective Solutions at the American Institutes for Research. She has 14 years of experience practicing in federally qualified health centers. Dr. Salisbury-Afshar lectures nationally on addiction medicine topics including the treatment of opioid use disorder, harm reduction, drug policy and the intersection of addiction and the criminal legal system, and public health approaches to reduce overdose mortality.
She is actively involved in ASAM and currently serves as the Chair of the Fundamentals of Addiction Medicine course, Co-Chair of the ASAM-All Rise "Integrating Addiction Medicine with Treatment Courts" course, a member of the Medical Education Committee, a member of the ASAM Conference Planning Committee, and the Chair of the Harm Reduction Special Interest Group.

She has no relevant financial disclosures.

Presentation(s):